<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JDR</journal-id>
<journal-id journal-id-type="hwp">spjdr</journal-id>
<journal-id journal-id-type="nlm-ta">J Dent Res</journal-id>
<journal-title>Journal of Dental Research</journal-title>
<issn pub-type="ppub">0022-0345</issn>
<issn pub-type="epub">1544-0591</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0022034512467803</article-id>
<article-id pub-id-type="publisher-id">10.1177_0022034512467803</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Reports</subject>
<subj-group subj-group-type="heading">
<subject>Biological</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Hyperocclusion Up-regulates CCL3 Expression in CCL2- and CCR2-deficient Mice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Tsutsumi</surname><given-names>T.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034512467803">1</xref>
<xref ref-type="aff" rid="aff2-0022034512467803">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Kajiya</surname><given-names>H.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034512467803">1</xref>
<xref ref-type="corresp" rid="corresp1-0022034512467803">*</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Goto</surname><given-names>K.T.</given-names></name>
<xref ref-type="aff" rid="aff3-0022034512467803">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Takahashi</surname><given-names>Y.</given-names></name>
<xref ref-type="aff" rid="aff2-0022034512467803">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Okabe</surname><given-names>K.</given-names></name>
<xref ref-type="aff" rid="aff1-0022034512467803">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0022034512467803"><label>1</label>Department of Physiological Science and Molecular Biology, Fukuoka Dental College, 2-15-1 Tamura, Sawara-ku, Fukuoka 8140193, Japan</aff>
<aff id="aff2-0022034512467803"><label>2</label>Department of Oral Rehabilitation, Fukuoka Dental College, Fukuoka, Japan</aff>
<aff id="aff3-0022034512467803"><label>3</label>Department of Dental Hygiene, Fukuoka College of Health Sciences, Fukuoka, Japan</aff>
<author-notes>
<corresp id="corresp1-0022034512467803"><label>*</label><email>kajiya@college.fdcnet.ac.jp</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2013</year>
</pub-date>
<volume>92</volume>
<issue>1</issue>
<fpage>65</fpage>
<lpage>70</lpage>
<history>
<date date-type="received">
<day>3</day>
<month>8</month>
<year>2012</year>
</date>
<date date-type="rev-recd">
<day>17</day>
<month>10</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>10</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© 2013 International &amp; American Associations for Dental Research</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="society">International &amp; American Associations for Dental Research</copyright-holder>
</permissions>
<abstract>
<p>Excessive mechanical stress (MS) during hyperocclusion is known to result in disappearance of the alveolar hard line, enlargement of the periodontal ligament (PDL) space, and destruction of alveolar bone, leading to occlusal traumatism. We have recently reported that MS induces predominantly C-C chemokine ligand (CCL) 2 expression in PDL tissues, leading, <italic>via</italic> C-C chemokine receptor (CCR) 2, to MS-dependent osteoclastogenesis in alveolar bone. Thus, we hypothesize that ablation of the CCL2/CCR2 signaling pathway should suppress MS-induced osteoclastogenesis-associated chemokines and alleviate occlusal traumatism. We examined the effect of MS on chemokine expression and osteoclastogenesis using <italic>in vivo</italic> and <italic>in vitro</italic> hyperocclusion models with CCL2-deficient (CCL2<sup>(-/-)</sup>) and CCR2-deficient (CCR2<sup>(-/-)</sup>) mice. Compared with that in wild-type mice, expression of CCL3 in PDL cells and TRAP-positive cells in alveolar bone from CCL2<sup>(-/-)</sup> and CCR2<sup>(-/-)</sup> mice was up-regulated, even in the absence of MS. Furthermore, the expression of CCL3 and TRAP-positive cells was significantly increased after both 4 and 7 days of hyperocclusal MS loading in CCL2<sup>(-/-)</sup> and CCR2<sup>(-/-)</sup> mice. Hyperocclusion induced compensatory CCL3 expression and promoted osteoclastogenesis to counterbalance deficient CCL2/CCR2 signaling, suggesting that co-expression of CCL3 with CCL2 may precipitate synergistic, MS-dependent alveolar bone destruction during occlusal traumatism.<italic>Abbreviations</italic>: MS, mechanical stress; PDL, periodontal ligament; CCL2, CC chemokine ligand 2 (MCP-1; monocyte chemoattractant protein-1); CCR2, CC chemokine receptor 2; CCL3, CC chemokine ligand 3 (MIP-1α); CCL5, CC chemokine ligand 5 (RANTES).</p>
</abstract>
<kwd-group>
<kwd>chemokine CCL3</kwd>
<kwd>traumatic dental occlusion</kwd>
<kwd>mechanical stress</kwd>
<kwd>bone resorption</kwd>
<kwd>periodontal ligament</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0022034512467803" sec-type="intro">
<title>Introduction</title>
<p>Premature occlusal contact and lateral jiggling of abutment teeth in partial dentures results in excessive forces being exerted on periodontal tissues. Excessive mechanical stress (MS) during hyperocclusion has been shown to induce disappearance of the alveolar hard line, enlargement of the periodontal ligament (PDL) space, and damage to periodontal tissues, resulting in bone resorption and tooth loss (<xref ref-type="bibr" rid="bibr28-0022034512467803">Yoshinaga <italic>et al</italic>., 2007</xref>; <xref ref-type="bibr" rid="bibr27-0022034512467803">Walker <italic>et al</italic>., 2008</xref>). In contrast, MS produced by normal occlusion has an inhibitory effect on unopposed eruption and physiological drifting of teeth (<xref ref-type="bibr" rid="bibr27-0022034512467803">Walker <italic>et al</italic>., 2008</xref>).</p>
<p>Chemokines are a large family of chemotactic cytokines that direct the trafficking and homing of specific subpopulations of leukocytes and other cells, in both physiologic and pathologic processes (<xref ref-type="bibr" rid="bibr21-0022034512467803">Rossi and Zlotnik, 2000</xref>; <xref ref-type="bibr" rid="bibr11-0022034512467803">Gerard and Rollins, 2001</xref>). Among the chemokine family, CCL2 (MCP-1), CCL3 (MIP-1α), and CCL5 (RANTES) have been identified as typical osteoclastogenesis-associated chemokines. These contribute to osteoclast recruitment and activation (<xref ref-type="bibr" rid="bibr5-0022034512467803">Chae <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="bibr13-0022034512467803">Graves <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="bibr24-0022034512467803">Toh <italic>et al</italic>., 2004</xref>). A recent study has shown that CCL2, CCL3, and CCL5 are involved in human osteoclast differentiation from osteoclast precursors <italic>in vitro</italic> (<xref ref-type="bibr" rid="bibr14-0022034512467803">Kim <italic>et al</italic>., 2006</xref>). Several studies have also reported that MS induced the expression of cytokines and chemokines in alveolar bone resorption during periodontitis and orthodontic tooth movement (<xref ref-type="bibr" rid="bibr2-0022034512467803">Andrade <italic>et al</italic>., 2007</xref>; <xref ref-type="bibr" rid="bibr23-0022034512467803">Silva <italic>et al</italic>., 2007</xref>; <xref ref-type="bibr" rid="bibr9-0022034512467803">Garlet <italic>et al</italic>., 2008</xref>). We have recently reported that excessive MS with hyperocclusion predominantly induces CCL2 expression in rat PDL tissues, leading to MS-dependent osteoclastogenesis in alveolar bone in <italic>in vitro</italic> and <italic>in vivo</italic> rodent models of hyperocclusion (<xref ref-type="bibr" rid="bibr12-0022034512467803">Goto <italic>et al</italic>., 2011</xref>).</p>
<p>Thus, we hypothesize that ablation of the CCL2/CCR2 signaling pathway should inhibit the expression of osteoclastogenesis-associated chemokines in the PDL, preventing occlusal traumatism. We have examined the effects of MS on chemokine expression and osteoclastogenesis using <italic>in vivo</italic> and <italic>in vitro</italic> hyperocclusion models in which either CCL2 (CCL2<sup>(-/-)</sup>) or CCR2 (CCR2<sup>(-/-)</sup>) are deficient compared with wild-type (WT) mice.</p>
</sec>
<sec id="section2-0022034512467803" sec-type="materials|methods">
<title>Materials &amp; Methods</title>
<sec id="section3-0022034512467803">
<title>Experimental Animals</title>
<p>Five-week-old C57BL/6 mice were used unmodified (WT) or with CCL2 (CCL2<sup>(-/-)</sup>) or CCR2 (CCR2<sup>(-/-)</sup>) knocked out. Mice were purchased from Kyudo Animal Co. Ltd. (Tosu, Saga, Japan) and Jackson Lab (Sacramento, CA, USA). All animals were treated according to the ethical regulations for animal experimentation defined by the Animal Care Committee of the Fukuoka Dental College, Fukuoka, Japan.</p>
</sec>
<sec id="section4-0022034512467803">
<title>Cell Culture</title>
<p>Primary cultures of mouse PDL cells were established from WT, CCL2<sup>(-/-)</sup>, and CCR2<sup>(-/-)</sup> mice. Mice were sacrificed by being injected with an excess of isoflurane anesthesia. Mandibles from 5 mice were hemisected into left and right halves by incision through the midline symphysis, dissected from surrounding tissues, rinsed twice in phosphate-buffered saline, and stored in serum-free Dulbecco’s Modified Eagle Medium (DMEM, Sigma-Aldrich, St. Louis, MO, USA). Using a stereomicroscope, we extracted first molars by incising the periodontal ligament attaching them to the surrounding alveolar bone; teeth were then rinsed and stored in PBS. Collagenase and trypsin were used to remove PDL cells enzymatically from the surfaces of the molars. For this procedure, teeth were placed into a centrifuge tube containing DMEM augmented with 2 mg/mL collagenase (Wako Co. Ltd., Osaka, Japan) and 0.25% trypsin (Wako) and incubated for 15 min at 37°C. Additional DMEM containing collagenase and trypsin was then added to the tube and incubated for a further 2 hrs. PDL cells were then collected by centrifugation at 400 <italic>g</italic> for 5 min, re-suspended in DMEM containing 20% fetal bovine serum, 100 U/mL penicillin, and 100 µg/mL streptomycin and cultured in a dish at 37°C in a humidified gas mixture of 5% CO<sub>2</sub>/95% air.</p>
</sec>
<sec id="section5-0022034512467803">
<title><italic>In vitro</italic> Intermittent Stretching Model of Mechanical Stress</title>
<p>Mouse PDL cells were cultured in a 50-cm<sup>2</sup> silicon chamber at a density of 5 × 10<sup>5</sup> cells/cm<sup>2</sup>. The silicon chamber was attached to a stretching apparatus (STB-140, Strex Co. Ltd., Osaka, Japan) and subjected to intermittent uniaxial stretching (60 sec/return; 29 sec resting time; 1.6 mm stretch length; 105% stretch ratio) for 1 to 4 days.</p>
</sec>
<sec id="section6-0022034512467803">
<title><italic>In vivo</italic> Hyperocclusion Model</title>
<p>Anesthesia was achieved with diethyl ether and pentobarbital (50 mg/kg, Kyoritsu, Tokyo, Japan). To create a hyperocclusive state, we modified the 3 right maxillary molars to accept a stainless steel wire bonded with methylmethacrylate resin (Super-Bond; Sun Medical Inc., Shiga, Japan). Stainless steel wire (0.3 mm diameter) was bonded to the occlusal surfaces of the right maxillary molars in mice, according to our previous study (<xref ref-type="bibr" rid="bibr12-0022034512467803">Goto <italic>et al</italic>., 2011</xref>).</p>
</sec>
<sec id="section7-0022034512467803">
<title>RNA Isolation, Reverse-transcription/Polymerase Chain-reaction (RT-PCR)</title>
<p>Total RNA was extracted from PDL cells with TRIzol reagent. First-strand cDNA was synthesized with 3 μg total RNA with SuperScript II Reverse Transcriptase (Invitrogen, Carlsbad, CA, USA). The cDNA was amplified by PCR (denaturation, 1 min, 95°C; annealing, 1 min, 60°C; extension, 1 min, 72°C; 23 cycles) with specific primers. PCR products were subjected to electrophoresis on 2% agarose gels and visualized with ethidium bromide.</p>
</sec>
<sec id="section8-0022034512467803">
<title>Western Blot Analysis</title>
<p>Cells underwent lysis in buffer containing 20 mM Tris-HCl (pH 7.5), 200 mM NaCl, 1% Triton-X, 1 mM DTT, and protease inhibitors (Roche, Basel, Switzerland). The protein contents of the samples were measured with the use of a protein assay kit (Pierce, Hercules, CA, USA). Protein samples (20 μg) were subjected to 5 to 20% sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and transferred electrophoretically to a polyvinylidene fluoride membrane at 100 V for 1 hr at 4°C. The membrane was incubated with primary antibodies against CCL2, CCL3, and CCL5 (sc-30032, sc-33203, sc-1410; Santa Cruz Biotech, Delaware, CA, USA) at 1:500 dilutions in 5% skimmed milk solution overnight at 4°C. Blots were then incubated with horseradish-peroxidase-conjugated goat anti-rabbit or mouse IgG in 5% skimmed milk-TBST (10 mM Tris-HCl, 50 mM NaCl, 0.25% Tween-20) and developed in an enhanced chemiluminescence system (GE, Arlington Heights, IL, USA).</p>
</sec>
<sec id="section9-0022034512467803">
<title>Enzyme-linked Immunosorbent (ELISA) Assay</title>
<p>The amount of CCL3 secreted into the culture medium following stretching-induced MS of mouse PDL cells for 1 to 7 days was determined by ELISA assay (Bender Medsystems, Burlingame, CA, USA) according to the manufacturer’s recommended protocol.</p>
</sec>
<sec id="section10-0022034512467803">
<title>Immunohistochemistry</title>
<p>Mice were sacrificed at 0, 4, and 7 days after wire was bonded to the occlusal surface. The mandibles were dissected and immediately placed in a 4% paraformaldehyde solution for 24 hrs at 4°C for fixation. After fixation, specimens were decalcified for 2 wks in 10% EDTA solution. Specimens were dehydrated in 30% sucrose overnight, embedded in OCT compound, and frozen in dry ice/isopentane. Bone sections (6 µm in thickness) were prepared with Frigocut CM3050S (Leica, Wetzlar, Germany). Sections were incubated overnight at 4°C with the same primary antibodies against CCL2, CCL3, and CCL5 as used for Western blotting (1:500 in phosphate-buffered saline solution). Bound antibody was visualized with Alexa Fluor-conjugated IgG secondary antibody (1 µg/mL, Molecular Probes, Eugene, OR, USA) for 30 min at room temperature. Similar results were obtained in 5 independent experiments.</p>
</sec>
<sec id="section11-0022034512467803">
<title>Statistical Analysis</title>
<p>Data are expressed as mean values with standard errors (± SE) from (n) number of cells. Differences were analyzed by paired one-way analysis of variance, where appropriate. Values of <italic>p</italic> &lt; 0.05 were considered to be significant.</p>
</sec>
</sec>
<sec id="section12-0022034512467803" sec-type="results">
<title>Results</title>
<sec id="section13-0022034512467803">
<title>Effects of Stretching-induced MS on the Expression of CCL3 in CCL2-deficient, CCR2-deficient, and Wild-type PDL Cells in <italic>in vitro</italic> Models of Hyperocclusion</title>
<p>We examined the expression of CCL2, CCL3, and CCL5 at 0 and 4 days following stretching-induced MS in PDL cells derived from WT, CCL2<sup>(-/-)</sup>, and CCR2<sup>(-/-)</sup> mice, using conventional RT-PCR, real-time PCR, Western blotting, and ELISA methods (<xref ref-type="fig" rid="fig1-0022034512467803">Fig. 1</xref>, Appendix Fig.). The expression of CCL2 mRNA and protein significantly increased in WT PDL cells, but was accompanied by only a small amount of CCL3 and negligible CCL5 expression 4 days after stretching-induced MS (<xref ref-type="fig" rid="fig1-0022034512467803">Fig. 1</xref>). In contrast, CCL3 expression in CCL2<sup>(-/-)</sup> and CCR2<sup>(-/-)</sup> PDL cells was endogenously up-regulated in the absence of any MS, apparently to compensate for the loss of CCL2/CCR2 signaling. Furthermore, the expression of CCL3 mRNA and protein was further increased 4 days after stretching-induced MS. To clarify the amount and time-course of CCL3 protein release from the 3 types of PDL cells, we examined MS-induced CCL3 secretion using ELISA (Appendix Fig.). CCL3 protein secretion was temporally and quantitatively similar in all 3 cell types following stimulation.</p>
<fig id="fig1-0022034512467803" position="float">
<label>Figure 1.</label>
<caption>
<p>Effects of stretch-induced mechanical stress on the expression of CCL2, CCL3, and CCL5 mRNA and protein in periodontal ligament (PDL) cells from wild-type (WT), CCL2<sup>(-/-)</sup>, and CCR2<sup>(-/-)</sup> mice. (<bold>A</bold>) PDL cells from the 3 different mouse genotypes were intermittently stretched for either 0 or 4 days. Expression of CCL chemokines and GAPDH mRNAs was analyzed by reverse-transcriptase/polymerase chain-reaction (RT-PCR). Results shown are representative of 5 independent experiments. (<bold>B</bold>) Expression of CCL2, CCL3, CCL5, and β-actin mRNAs was analyzed by real-time PCR. Data represent the means ± SEM from 6 culture wells from different passages cells. *<italic>p</italic> &lt; 0.05 and **<italic>p</italic> &lt; 0.01 <italic>vs</italic>. day 0 of MS. (<bold>C</bold>) The expression levels of CCL2 and CCL3 proteins were detected by Western blot analysis. Results shown are representative of 3 independent experiments.</p>
</caption>
<graphic xlink:href="10.1177_0022034512467803-fig1.tif"/></fig>
</sec>
<sec id="section14-0022034512467803">
<title>Regulation of CCL3 Expression in <italic>in vivo</italic> Mouse Hyperocclusion Model with CCL2- and CCR2-deficient Mice</title>
<p>We examined the effects of MS during hyperocclusion on the expression of chemokines in a mouse <italic>in vivo</italic> hyperocclusion model using WT, CCL2<sup>(-/-)</sup>, and CCR2<sup>(-/-)</sup> mice (<xref ref-type="fig" rid="fig2-0022034512467803">Figs. 2</xref>, <xref ref-type="fig" rid="fig3-0022034512467803">3</xref>). No remarkable inflammation was detected by hematoxylin-eosin staining until 7 days after hyperocclusal MS in any mouse genotype in WT (<xref ref-type="fig" rid="fig2-0022034512467803">Fig. 2</xref>), CCL2<sup>(-/-)</sup>, and CCR2<sup>(-/-)</sup> mice (data not shown). Almost no TRAP-positive cells were observed before MS in WT mice, but these cells significantly increased in number in alveolar bone on day 4 of hyperocclusal MS, reaching a maximum on day 7 (<xref ref-type="fig" rid="fig2-0022034512467803">Fig. 2</xref>). Similarly, few CCL2-positive cells were detected before MS in WT mice, but these were increased in PDL tissues after 4 days of MS and peaked at 7 days (<xref ref-type="fig" rid="fig2-0022034512467803">Figs. 2</xref>, <xref ref-type="fig" rid="fig3-0022034512467803">3</xref>). The expression of CCL2 was especially localized to the periodontal tissue around the root furcation of the first molar after 4 and 7 days of hyperocclusal MS stimulation. CCL3 expression was negligible in these WT tissues.</p>
<fig id="fig2-0022034512467803" position="float">
<label>Figure 2.</label>
<caption>
<p>Phenotype of alveolar bone sections from WT mice. Alveolar bone sections from WT mice following 0 (<bold>left column</bold>), 4 (<bold>middle column</bold>), or 7 (<bold>right column</bold>) days of hyperocclusal MS stimulus were stained with hematoxylin-eosin (HE; upper row), and for tartrate-resistant acid phosphatase (TRAP; upper-middle row), CCL2 (lower-middle row), and CCL3 (lower row). Results shown are representative of 5 independent experiments. Arrowheads indicate TRAP-positive cells. Bars indicate 100 µm.</p>
</caption>
<graphic xlink:href="10.1177_0022034512467803-fig2.tif"/></fig>
<fig id="fig3-0022034512467803" position="float">
<label>Figure 3.</label>
<caption>
<p>TRAP staining of alveolar bone sections from WT, CCL2<sup>(-/-)</sup>, and CCR2<sup>(-/-)</sup> mice. (<bold>A</bold>) Alveolar bone sections from 3 phenotypes of mice following 0 (left column), 4 (middle column), or 7 (right column) days with (loading side) or without (unloading side) hyperocclusal MS stimulus were stained for TRAP. Results shown are representative of 5 independent experiments. Arrowheads indicate TRAP-positive cells. Bars indicate 100 µm. (<bold>B</bold>) Number of TRAP-positive cells in 3 mouse phenotypes with hyperocclusal MS loading. Data represent the means ± SEM from 7 sections in each mouse phenotype. *<italic>p</italic> &lt; 0.05 and **<italic>p</italic> &lt; 0.01 <italic>vs</italic>. day 0 of MS.</p>
</caption>
<graphic xlink:href="10.1177_0022034512467803-fig3.tif"/></fig>
<p>In contrast, in CCL2<sup>(-/-)</sup> and CCR2<sup>(-/-)</sup> mice, even in the absence of stimulation, TRAP-positive cells appeared in the alveolar bone (<xref ref-type="fig" rid="fig3-0022034512467803">Fig. 3</xref>), and CCL3 expression was up-regulated in the PDL tissues (<xref ref-type="fig" rid="fig4-0022034512467803">Fig. 4</xref>). The numbers of TRAP-positive cells in the hyperocclusal MS loading side of PDL tissues were significantly increased after 4 days of hyperocclusion compared with the unloading side, and peaked on day 7 in CCL2<sup>(-/-)</sup>and CCR2<sup>(-/-)</sup> mice (<xref ref-type="fig" rid="fig3-0022034512467803">Fig. 3</xref>). Furthermore, TRAP-positive cells were localized in the alveolar bone on day 4, but on day 7 were found nearer to the PDL space. CCL3 increased gradually in PDL tissues toward a maximum on day 7 after hyperocclusal MS in both knockout mice (<xref ref-type="fig" rid="fig4-0022034512467803">Fig. 4</xref>), but CCL5 was unchanged by this stimulation (data not shown). The expression of CCL2 was detected in CCR2 <sup>(-/-)</sup> PDL cells 4 and 7 days after MS.</p>
<fig id="fig4-0022034512467803" position="float">
<label>Figure 4.</label>
<caption>
<p>CCL3 immunostaining of alveolar bone sections from WT, CCL2<sup>(-/-)</sup>, and CCR2<sup>(-/-)</sup> mice. Alveolar bone sections from 3 mouse phenotypes following 0 (<bold>left column</bold>), 4 (<bold>middle column</bold>), or 7 (<bold>right column</bold>) days with or without hyperocclusal MS stimulus were immunostained for CCL3. Results shown are representative of 5 independent experiments. Bars indicate 100 µm.</p>
</caption>
<graphic xlink:href="10.1177_0022034512467803-fig4.tif"/></fig>
</sec>
</sec>
<sec id="section15-0022034512467803" sec-type="discussion">
<title>Discussion</title>
<p>There are some reports that CCL2, CCL3, and CCL5 are associated with osteoclast differentiation (<xref ref-type="bibr" rid="bibr5-0022034512467803">Chae <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="bibr13-0022034512467803">Graves <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="bibr24-0022034512467803">Toh <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="bibr14-0022034512467803">Kim <italic>et al</italic>., 2006</xref>). We have recently reported that excessive MS during hyperocclusion induces predominantly CCL2 expression in PDL tissues, leading to MS-dependent osteoclastogenesis in alveolar bone (<xref ref-type="bibr" rid="bibr12-0022034512467803">Goto <italic>et al</italic>., 2011</xref>). In the present study, we investigated the effects of negating the CCL2/CCR2 signaling pathways on MS-induced chemokine expression. We found that knockout of CCL2/CCR2 signaling caused compensatory expression of CCL3 and up-regulation of TRAP-positive cells at 7 days after MS. The MS-induced CCL3 secreted from PDL tissues may, through receptors such as CCR1 and CCR5, contribute to the differentiation and activation of osteoclasts in alveolar bone. These results suggest that the co-expression of CCL3 and CCL2 following hyperocclusal mechanical stress synergistically promotes the destruction of periodontal tissues and alveolar bone during occlusal traumatism.</p>
<p>It has recently been shown that CCL2, CCL3, and CCL5 play important roles in osteoclast recruitment, differentiation, and bone resorption activity during bone remodeling (<xref ref-type="bibr" rid="bibr19-0022034512467803">Okamatsu <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="bibr24-0022034512467803">Toh <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="bibr14-0022034512467803">Kim <italic>et al</italic>., 2006</xref>; <xref ref-type="bibr" rid="bibr16-0022034512467803">Masella and Meister, 2006</xref>; <xref ref-type="bibr" rid="bibr25-0022034512467803">Tsubaki <italic>et al</italic>., 2007</xref>). Osteoclast precursors are known to express CCR2 and CCR5 and to respond to chemokines such as CCL2, CCL3, and CXCL12 (<xref ref-type="bibr" rid="bibr3-0022034512467803">Bendre <italic>et al</italic>., 2003</xref>; <xref ref-type="bibr" rid="bibr29-0022034512467803">Yu <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="bibr23-0022034512467803">Silva <italic>et al</italic>., 2007</xref>). Furthermore, CCL2 and CCL3 expression levels are thought to be significantly higher in areas of alveolar bone that are under constant compression forces, which are characterized by high bone resorption activity during orthodontic tooth movement (<xref ref-type="bibr" rid="bibr1-0022034512467803">Alhashimi <italic>et al</italic>., 1999</xref>; <xref ref-type="bibr" rid="bibr8-0022034512467803">Garlet <italic>et al</italic>., 2007</xref>).</p>
<p>The expression of CCL2 and CCR2 has been reported to be stimulated by RANKL and NFκB (<xref ref-type="bibr" rid="bibr4-0022034512467803">Cappellen <italic>et al</italic>., 2002</xref>; <xref ref-type="bibr" rid="bibr17-0022034512467803">Miyamoto <italic>et al</italic>., 2009</xref>), indicating that CCL2 contributes to osteoclastogenesis and bone resorption. However, the expression of genes associated with bone resorption, such as cathepsin K and MMP9, was minimal in CCL2-induced osteoclasts, resulting in the inhibition of bone resorption (<xref ref-type="bibr" rid="bibr14-0022034512467803">Kim <italic>et al</italic>., 2006</xref>). Although CCL2 levels are markedly increased in joints displaying rheumatoid arthritis with abnormal bone resorption (<xref ref-type="bibr" rid="bibr15-0022034512467803">Koch, 2005</xref>), CCR2 gene ablation aggravates collagen-induced arthritis in rats. CCR2<sup>(-/-)</sup> mice exhibit enhanced intra-articular expression of CCL3 (<xref ref-type="bibr" rid="bibr20-0022034512467803">Quinones <italic>et al</italic>., 2004</xref>), which is involved in osteoclast recruitment and differentiation (<xref ref-type="bibr" rid="bibr19-0022034512467803">Okamatsu <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="bibr14-0022034512467803">Kim <italic>et al</italic>., 2006</xref>; <xref ref-type="bibr" rid="bibr25-0022034512467803">Tsubaki <italic>et al</italic>., 2007</xref>). <italic>In vitro</italic> studies have shown that CCL3 increases the expression of RANKL by osteoblasts and induces osteoclast-osteoblast interaction, increasing osteoclast differentiation and, consequently, accelerating bone resorption (<xref ref-type="bibr" rid="bibr26-0022034512467803">Watanabe <italic>et al</italic>., 2004</xref>; <xref ref-type="bibr" rid="bibr25-0022034512467803">Tsubaki <italic>et al</italic>., 2007</xref>). Furthermore, CCL3 is up-regulated in a multiple myeloma microenvironment and is correlated with osteolytic lesions and tumor burden, while inhibition of CCL3 significantly reduces bone destruction in a mouse model of multiple myeloma (<xref ref-type="bibr" rid="bibr7-0022034512467803">Choi <italic>et al</italic>., 2000</xref>). The expression levels of RANK and RANKL are decreased in CCL3<sup>(-/-)</sup> mice after mechanical loading, which is consistent with reduced bone resorption. Our current findings show that the <italic>in vivo</italic> and <italic>in vitro</italic> experimental models of MS used here also induce expression of CCL3 in WT PDL cells, in addition to CCL2. More importantly, when CCL2/CCR2 signaling is knocked out, CCL3 expression is dramatically elevated. The expression of CCL3 in PDL tissues was followed, temporally and spatially, by an increase in TRAP-positive cells, suggesting that alveolar bone resorption during occlusal traumatism is invoked not only by CCL2 but also by CCL3.</p>
<p>Previous studies have shown that neutrophil infiltration was augmented in mice deficient in CCL2 and CCR2 (<xref ref-type="bibr" rid="bibr18-0022034512467803">Montgomery <italic>et al</italic>., 2007</xref>; <xref ref-type="bibr" rid="bibr22-0022034512467803">Sawanobori <italic>et al</italic>., 2008</xref>). CCL2<sup>(-/-)</sup> and CCR2<sup>(-/-)</sup> mice showed impaired recruitment of macrophages, expressed higher levels of inflammatory osteolytic factors, and exhibited an increased number of TRAP-positive cells (<xref ref-type="bibr" rid="bibr10-0022034512467803">Garlet <italic>et al</italic>., 2010</xref>; <xref ref-type="bibr" rid="bibr6-0022034512467803">Chen <italic>et al</italic>., 2011</xref>). In the present experiments, we found that CCL3 expression in PDL tissues and TRAP-positive cells in alveolar bone were both up-regulated in CCL2<sup>(-/-)</sup> and CCR2<sup>(-/-)</sup> mice, even in the absence of hyperocclusal MS, consistent with the findings of the previous study. The MS increased both CCL3 expression and the number of TRAP-positive cells after both 4 and 7 days of MS stimulation. These results indicate that the expression and activation of CCL3 could be induced not only by inflammation of periodontal tissue, but also by MS during hyperocclusion in situations where CCL2/CCR2 signaling is deficient. Furthermore, the inhibition of CCL2 and CCL3 signaling that occurs following hyperocclusal MS might be an adjunctive therapy in conventional oral rehabilitation that might be able to promote recovery of alveolar bone formation after occlusal adjustment.</p>
<p>In summary, CCL2 and CCL3 both appear to have roles in osteoclast differentiation, and thus alveolar bone resorption, induced by hyperocclusal MS loading.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="supported-by">
<p>This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24592823) and the Strategic Study Base Formation Support Business (S1001059).</p>
</fn>
<fn fn-type="conflict">
<p>The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.</p>
</fn>
<fn fn-type="supplementary-material">
<p>A supplemental appendix to this article is published electronically only at <ext-link ext-link-type="uri" xlink:href="http://jdr.sagepub.com/supplemental">http://jdr.sagepub.com/supplemental</ext-link>.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Alhashimi</surname><given-names>N</given-names></name>
<name><surname>Frithiof</surname><given-names>L</given-names></name>
<name><surname>Brudvik</surname><given-names>P</given-names></name>
<name><surname>Bakhiet</surname><given-names>M</given-names></name>
</person-group> (<year>1999</year>). <article-title>Chemokines are upregulated during orthodontic tooth movement</article-title>. <source>J Interferon Cytokine Res</source> <volume>19</volume>:<fpage>1047</fpage>-<lpage>1052</lpage>.</citation>
</ref>
<ref id="bibr2-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Andrade</surname><given-names>I</given-names><suffix>Jr</suffix></name>
<name><surname>Silva</surname><given-names>TA</given-names></name>
<name><surname>Silva</surname><given-names>GA</given-names></name>
<name><surname>Teixeira</surname><given-names>AL</given-names></name>
<name><surname>Teixeira</surname><given-names>MM</given-names></name>
</person-group> (<year>2007</year>). <article-title>The role of tumor necrosis factor receptor type 1 in orthodontic tooth movement</article-title>. <source>J Dent Res</source> <volume>86</volume>:<fpage>1089</fpage>-<lpage>1094</lpage>.</citation>
</ref>
<ref id="bibr3-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bendre</surname><given-names>MS</given-names></name>
<name><surname>Montague</surname><given-names>DC</given-names></name>
<name><surname>Peery</surname><given-names>T</given-names></name>
<name><surname>Akel</surname><given-names>NS</given-names></name>
<name><surname>Gaddy</surname><given-names>D</given-names></name>
<name><surname>Suva</surname><given-names>LJ</given-names></name>
</person-group> (<year>2003</year>). <article-title>Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease</article-title>. <source>Bone</source> <volume>33</volume>:<fpage>28</fpage>-<lpage>37</lpage>.</citation>
</ref>
<ref id="bibr4-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cappellen</surname><given-names>D</given-names></name>
<name><surname>Luong-Nguyen</surname><given-names>NH</given-names></name>
<name><surname>Bongiovanni</surname><given-names>S</given-names></name>
<name><surname>Grenet</surname><given-names>O</given-names></name>
<name><surname>Wanke</surname><given-names>C</given-names></name>
<name><surname>Susa</surname><given-names>M</given-names></name>
</person-group> ( <year>2002</year>). <article-title>Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFkappa B</article-title>. <source>J Biol Chem</source> <volume>277</volume>:<fpage>21971</fpage>-<lpage>21982</lpage>.</citation>
</ref>
<ref id="bibr5-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chae</surname><given-names>P</given-names></name>
<name><surname>Im</surname><given-names>M</given-names></name>
<name><surname>Gibson</surname><given-names>F</given-names></name>
<name><surname>Jiang</surname><given-names>Y</given-names></name>
<name><surname>Graves</surname><given-names>DT</given-names></name>
</person-group> (<year>2002</year>). <article-title>Mice lacking monocyte chemoattractant protein 1 have enhanced susceptibility to an interstitial polymicrobial infection due to impaired monocyte recruitment</article-title>. <source>Infect Immun</source> <volume>70</volume>:<fpage>3164</fpage>-<lpage>3169</lpage>.</citation>
</ref>
<ref id="bibr6-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>M</given-names></name>
<name><surname>Forrester</surname><given-names>JV</given-names></name>
<name><surname>Xu</surname><given-names>H</given-names></name>
</person-group> (<year>2011</year>). <article-title>Dysregulation in retinal para-inflammation and age-related retinal degeneration in CCL2 or CCR2 deficient mice</article-title>. <source>PLoS One</source> <volume>6</volume>:<fpage>e22818</fpage>.</citation>
</ref>
<ref id="bibr7-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Choi</surname><given-names>SJ</given-names></name>
<name><surname>Cruz</surname><given-names>JC</given-names></name>
<name><surname>Craig</surname><given-names>F</given-names></name>
<name><surname>Chung</surname><given-names>H</given-names></name>
<name><surname>Devlin</surname><given-names>RD</given-names></name>
<name><surname>Roodman</surname><given-names>GD</given-names></name>
<etal/></person-group>. (<year>2000</year>). <article-title>Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma</article-title>. <source>Blood</source> <volume>96</volume>:<fpage>671</fpage>-<lpage>675</lpage>.</citation>
</ref>
<ref id="bibr8-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Garlet</surname><given-names>TP</given-names></name>
<name><surname>Coelho</surname><given-names>U</given-names></name>
<name><surname>Silva</surname><given-names>JS</given-names></name>
<name><surname>Garlet</surname><given-names>GP</given-names></name>
</person-group> (<year>2007</year>). <article-title>Cytokine expression pattern in compression and tension sides of the periodontal ligament during orthodontic tooth movement in humans</article-title>. <source>Eur J Oral Sci</source> <volume>115</volume>:<fpage>355</fpage>-<lpage>362</lpage>.</citation>
</ref>
<ref id="bibr9-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Garlet</surname><given-names>TP</given-names></name>
<name><surname>Coelho</surname><given-names>U</given-names></name>
<name><surname>Repeke</surname><given-names>CE</given-names></name>
<name><surname>Silva</surname><given-names>JS</given-names></name>
<name><surname>Cunha</surname><given-names>FQ</given-names></name>
<name><surname>Garlet</surname><given-names>GP</given-names></name>
</person-group> (<year>2008</year>). <article-title>Differential expression of osteoblast and osteoclast chemoattractants in compression and tension sides during orthodontic movement</article-title>. <source>Cytokine</source> <volume>42</volume>:<fpage>330</fpage>-<lpage>335</lpage>.</citation>
</ref>
<ref id="bibr10-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Garlet</surname><given-names>TP</given-names></name>
<name><surname>Fukada</surname><given-names>SY</given-names></name>
<name><surname>Saconato</surname><given-names>IF</given-names></name>
<name><surname>Avila-Campos</surname><given-names>MJ</given-names></name>
<name><surname>da Silva</surname><given-names>TA</given-names></name>
<name><surname>Garlet</surname><given-names>GP</given-names></name>
<etal/></person-group>. (<year>2010</year>). <article-title>CCR2 deficiency results in increased osteolysis in experimental periapical lesions in mice</article-title>. <source>J Endod</source> <volume>36</volume>:<fpage>244</fpage>-<lpage>250</lpage>.</citation>
</ref>
<ref id="bibr11-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gerard</surname><given-names>C</given-names></name>
<name><surname>Rollins</surname><given-names>BJ</given-names></name>
</person-group> (<year>2001</year>). <article-title>Chemokines and disease</article-title>. <source>Nat Immunol</source> <volume>2</volume>:<fpage>108</fpage>-<lpage>115</lpage>.</citation>
</ref>
<ref id="bibr12-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Goto</surname><given-names>TK</given-names></name>
<name><surname>Kajiya</surname><given-names>H</given-names></name>
<name><surname>Nemoto</surname><given-names>T</given-names></name>
<name><surname>Tsustumi</surname><given-names>T</given-names></name>
<name><surname>Tsuzuki</surname><given-names>T</given-names></name>
<name><surname>Sato</surname><given-names>H</given-names></name>
<etal/></person-group>. (<year>2011</year>). <article-title>Hyperocclusion stimulates osteoclastogenesis via CCL2</article-title>. <source>J Dent Res</source> <volume>90</volume>:<fpage>793</fpage>-<lpage>798</lpage>.</citation>
</ref>
<ref id="bibr13-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Graves</surname><given-names>DT</given-names></name>
<name><surname>Alsulaimani</surname><given-names>F</given-names></name>
<name><surname>Ding</surname><given-names>Y</given-names></name>
<name><surname>Marks</surname><given-names>SC</given-names><suffix>Jr</suffix></name>
</person-group> (<year>2002</year>). <article-title>Developmentally regulated monocyte recruitment and bone resorption are modulated by functional deletion of the monocytic chemoattractant protein-1 gene</article-title>. <source>Bone</source> <volume>31</volume>:<fpage>282</fpage>-<lpage>287</lpage>.</citation>
</ref>
<ref id="bibr14-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>MS</given-names></name>
<name><surname>Day</surname><given-names>CJ</given-names></name>
<name><surname>Selinger</surname><given-names>CI</given-names></name>
<name><surname>Magno</surname><given-names>CL</given-names></name>
<name><surname>Stephens</surname><given-names>SR</given-names></name>
<name><surname>Morrison</surname><given-names>NA</given-names></name>
</person-group> (<year>2006</year>). <article-title>MCP-1 induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption</article-title>. <source>J Biol Chem</source> <volume>281</volume>:<fpage>1274</fpage>-<lpage>1285</lpage>.</citation>
</ref>
<ref id="bibr15-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Koch</surname><given-names>AE</given-names></name>
</person-group> (<year>2005</year>). <article-title>Chemokines and their receptors in rheumatoid arthritis: future targets?</article-title> <source>Arthritis Rhem</source> <volume>52</volume>:<fpage>710</fpage>-<lpage>721</lpage>.</citation>
</ref>
<ref id="bibr16-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Masella</surname><given-names>RS</given-names></name>
<name><surname>Meister</surname><given-names>M</given-names></name>
</person-group> (<year>2006</year>). <article-title>Current concepts in the biology of orthodontic tooth movement</article-title>. <source>Am J Orthod Dentofacial Orthop</source> <volume>129</volume>:<fpage>458</fpage>-<lpage>468</lpage>.</citation>
</ref>
<ref id="bibr17-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Miyamoto</surname><given-names>K</given-names></name>
<name><surname>Ninomiya</surname><given-names>K</given-names></name>
<name><surname>Sonoda</surname><given-names>KH</given-names></name>
<name><surname>Miyauchi</surname><given-names>Y</given-names></name>
<name><surname>Hoshi</surname><given-names>H</given-names></name>
<name><surname>Iwasaki</surname><given-names>R</given-names></name>
<etal/></person-group>. (<year>2009</year>). <article-title>MCP-1 expressed by osteoclasts stimulates osteoclastogenesis in an autocrine/paracrine manner</article-title>. <source>Biochem Biophys Res Commun</source> <volume>383</volume>:<fpage>373</fpage>-<lpage>377</lpage>.</citation>
</ref>
<ref id="bibr18-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Montgomery</surname><given-names>RR</given-names></name>
<name><surname>Booth</surname><given-names>CJ</given-names></name>
<name><surname>Wang</surname><given-names>X</given-names></name>
<name><surname>Blaho</surname><given-names>VA</given-names></name>
<name><surname>Malawista</surname><given-names>SE</given-names></name>
<name><surname>Brown</surname><given-names>CR</given-names></name>
</person-group> (<year>2007</year>). <article-title>Recruitment of macrophages and polymorphonuclear leukocytes in L:yme carditis</article-title>. <source>Infect Immun</source> <volume>75</volume>:<fpage>613</fpage>-<lpage>620</lpage>.</citation>
</ref>
<ref id="bibr19-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Okamatsu</surname><given-names>Y</given-names></name>
<name><surname>Kim</surname><given-names>D</given-names></name>
<name><surname>Battaglino</surname><given-names>R</given-names></name>
<name><surname>Sasaki</surname><given-names>H</given-names></name>
<name><surname>Späte</surname><given-names>U</given-names></name>
<name><surname>Stashenko</surname><given-names>P</given-names></name>
</person-group> (<year>2004</year>). <article-title>MIP-1 gamma promotes receptor-activator-of-NF-kappa-B-ligand-induced osteoclast formation and survival</article-title>. <source>J Immunol</source> <volume>173</volume>:<fpage>2084</fpage>-<lpage>2090</lpage>.</citation>
</ref>
<ref id="bibr20-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Quinones</surname><given-names>MP</given-names></name>
<name><surname>Ahuja</surname><given-names>SK</given-names></name>
<name><surname>Jimenez</surname><given-names>F</given-names></name>
<name><surname>Schaefer</surname><given-names>J</given-names></name>
<name><surname>Garavito</surname><given-names>E</given-names></name>
<name><surname>Rao</surname><given-names>A</given-names></name>
<etal/></person-group>. (<year>2004</year>). <article-title>Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis</article-title>. <source>J Clin Invest</source> <volume>113</volume>:<fpage>856</fpage>-<lpage>866</lpage>.</citation>
</ref>
<ref id="bibr21-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rossi</surname><given-names>D</given-names></name>
<name><surname>Zlotnik</surname><given-names>A</given-names></name>
</person-group> (<year>2000</year>). <article-title>The biology of chemokines and their receptors</article-title>. <source>Annu Rev Immunol</source> <volume>18</volume>:<fpage>217</fpage>-<lpage>242</lpage>.</citation>
</ref>
<ref id="bibr22-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sawanobori</surname><given-names>Y</given-names></name>
<name><surname>Ueha</surname><given-names>S</given-names></name>
<name><surname>Kurachi</surname><given-names>M</given-names></name>
<name><surname>Shimaoka</surname><given-names>T</given-names></name>
<name><surname>Talmadge</surname><given-names>JE</given-names></name>
<name><surname>Abe</surname><given-names>J</given-names></name>
<etal/></person-group>. (<year>2008</year>). <article-title>Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice</article-title>. <source>Blood</source> <volume>111</volume>:<fpage>5457</fpage>-<lpage>5466</lpage>.</citation>
</ref>
<ref id="bibr23-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Silva</surname><given-names>TA</given-names></name>
<name><surname>Garlet</surname><given-names>GP</given-names></name>
<name><surname>Fukuda</surname><given-names>SY</given-names></name>
<name><surname>Silva</surname><given-names>JS</given-names></name>
<name><surname>Cunha</surname><given-names>FQ</given-names></name>
</person-group> (<year>2007</year>). <article-title>Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease</article-title>. <source>J Dent Res</source> <volume>86</volume>:<fpage>306</fpage>-<lpage>319</lpage>.</citation>
</ref>
<ref id="bibr24-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Toh</surname><given-names>K</given-names></name>
<name><surname>Kukita</surname><given-names>T</given-names></name>
<name><surname>Wu</surname><given-names>Z</given-names></name>
<name><surname>Kukita</surname><given-names>A</given-names></name>
<name><surname>Sandra</surname><given-names>F</given-names></name>
<name><surname>Tang</surname><given-names>QY</given-names></name>
<etal/></person-group>. (<year>2004</year>). <article-title>Possible involvement of MIP-1a in the recruitment of osteoclast progenitors to the distal tibia in rats with adjuvant-induced arthritis</article-title>. <source>Lab Invest</source> <volume>84</volume>:<fpage>1092</fpage>-<lpage>1102</lpage>.</citation>
</ref>
<ref id="bibr25-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tsubaki</surname><given-names>M</given-names></name>
<name><surname>Kato</surname><given-names>C</given-names></name>
<name><surname>Manno</surname><given-names>M</given-names></name>
<name><surname>Ogaki</surname><given-names>M</given-names></name>
<name><surname>Satou</surname><given-names>T</given-names></name>
<name><surname>Itoh</surname><given-names>T</given-names></name>
<etal/></person-group>. (<year>2007</year>). <article-title>Macrophage inflammatory protein-1alpha (MIP-1alpha) enhances a receptor activator of nuclear factor kappaB ligand (RANKL) expression in mouse bone marrow stromal cells and osteoblasts through MAPK and PI3K/Akt pathways</article-title>. <source>Mol Cell Biochem</source> <volume>304</volume>:<fpage>53</fpage>-<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr26-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Watanabe</surname><given-names>T</given-names></name>
<name><surname>Kukita</surname><given-names>T</given-names></name>
<name><surname>Kukita</surname><given-names>A</given-names></name>
<name><surname>Wada</surname><given-names>N</given-names></name>
<name><surname>Toh</surname><given-names>K</given-names></name>
<name><surname>Nagata</surname><given-names>K</given-names></name>
<etal/></person-group>. (<year>2004</year>). <article-title>Direct stimulation of osteoclastogenesis by MIP-1alpha: evidence obtained from studies using RAW264 cell clone highly responsive to RANKL</article-title>. <source>J Endocrinol</source> <volume>180</volume>:<fpage>193</fpage>-<lpage>201</lpage>.</citation>
</ref>
<ref id="bibr27-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Walker</surname><given-names>CG</given-names></name>
<name><surname>Ito</surname><given-names>Y</given-names></name>
<name><surname>Dangaria</surname><given-names>S</given-names></name>
<name><surname>Luan</surname><given-names>X</given-names></name>
<name><surname>Diekwisch</surname><given-names>TG</given-names></name>
</person-group> (<year>2008</year>). <article-title>RANKL, osteopontin, and osteoclast homeostasis in a hyperocclusion mouse model</article-title>. <source>Eur J Oral Sci</source> <volume>116</volume>:<fpage>312</fpage>-<lpage>318</lpage>.</citation>
</ref>
<ref id="bibr28-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yoshinaga</surname><given-names>Y</given-names></name>
<name><surname>Ukai</surname><given-names>T</given-names></name>
<name><surname>Abe</surname><given-names>Y</given-names></name>
<name><surname>Hara</surname><given-names>Y</given-names></name>
</person-group> (<year>2007</year>). <article-title>Expression of receptor activator of nuclear factor kappa B ligand relates to inflammatory bone resorption, with or without occlusal trauma, in rats</article-title>. <source>J Periodontal Res</source> <volume>42</volume>:<fpage>402</fpage>-<lpage>409</lpage>.</citation>
</ref>
<ref id="bibr29-0022034512467803">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yu</surname><given-names>X</given-names></name>
<name><surname>Huang</surname><given-names>Y</given-names></name>
<name><surname>Collin-Osdoby</surname><given-names>P</given-names></name>
<name><surname>Osdoby</surname><given-names>P</given-names></name>
</person-group> (<year>2004</year>). <article-title>CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts</article-title>. <source>J Bone Miner Res</source> <volume>19</volume>:<fpage>2065</fpage>-<lpage>2077</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>